FDA Struggles To Contain IOL Competitive Claims, Issues Pharmacia Warning
This article was originally published in The Gray Sheet
Executive Summary
Pharmacia is the third intraocular lens company in the last three years to be cited by FDA for improper marketing claims related to posterior capsule opacification (PCO).